Colab Platforms Limited has announced the grant of 813 stock options to eligible employees under its Employee Stock Option Plan 2024, marking a significant step in the company's employee retention and incentive strategy. The Nomination and Remuneration Committee of the Board of Directors approved this grant on January 7, 2026, in compliance with regulatory requirements.

ESOP Grant Details

The stock options were granted under the Colab Cloud Employee Stock Option Plan 2024, following the guidelines established by SEBI regulations. The grant encompasses specific parameters designed to align employee interests with company performance.

Regulatory Compliance

The grant adheres to Regulation 30 and Para B of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Additionally, it complies with SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Vesting and Exercise Terms

The stock options come with structured vesting and exercise provisions designed to ensure long-term employee commitment. The vesting schedule will be specified in individual grant letters issued to eligible employees.

Current Status

As of the grant date, no options have been vested or exercised, which is expected given the recent approval. The options will vest according to the schedule outlined in individual grant letters, with employees having the opportunity to exercise their options within one year of vesting.

The announcement was made through a formal communication to BSE Limited, with Managing Director Puneet Singh Chandhok signing the disclosure document. This ESOP grant represents Colab Platforms Limited's commitment to employee participation in the company's growth and success through equity-based compensation.

Colab Platforms Limited has announced the appointment of Mrs. Manali Karangutkar as Additional Non-executive Independent Director, effective December 30, 2025. The decision was made during a board meeting held on December 30, 2025, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Details

The board meeting that approved this appointment commenced at 6:30 PM and concluded at 7:15 PM on December 30, 2025. The company has informed BSE Limited about this development as part of its regulatory disclosure obligations.

Appointment Particulars

The key details of Mrs. Karangutkar's appointment are structured as follows:

Director Profile and Qualifications

Mrs. Manali Karangutkar brings extensive experience in the field of administration to her new role. The company has indicated that her expertise will serve as a valuable asset for the organization's growth initiatives. She has no inter se relationship with the existing board members, maintaining the independence required for her position.

Regulatory Compliance

The appointment has been made in accordance with SEBI regulations, and Mrs. Karangutkar is not debarred from holding the office of Director by virtue of any SEBI order. The disclosure has been made pursuant to Regulation 30 of the SEBI Listing Regulations and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

Next Steps

While the board has approved Mrs. Karangutkar's appointment as Additional Non-executive Independent Director, the five-year term is subject to approval from the company's shareholders. This appointment reflects Colab Platforms Limited's commitment to strengthening its board composition with experienced professionals who can contribute to the company's strategic direction and governance framework.